0001144204-18-039106.txt : 20180720
0001144204-18-039106.hdr.sgml : 20180720
20180720131333
ACCESSION NUMBER: 0001144204-18-039106
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180719
FILED AS OF DATE: 20180720
DATE AS OF CHANGE: 20180720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DHILLON AVTAR S
CENTRAL INDEX KEY: 0001260933
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54986
FILM NUMBER: 18962084
MAIL ADDRESS:
STREET 1: C/O GENETRONICS INC
STREET 2: 11199 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arch Therapeutics, Inc.
CENTRAL INDEX KEY: 0001537561
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 460524102
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 235 WALNUT STREET, SUITE 6
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
BUSINESS PHONE: 617-431-2313
MAIL ADDRESS:
STREET 1: 235 WALNUT STREET, SUITE 6
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
FORMER COMPANY:
FORMER CONFORMED NAME: ALMAH,INC
DATE OF NAME CHANGE: 20111216
4/A
1
tv498917_4a.xml
FORM 4/A
X0306
4/A
2018-07-19
2018-07-20
1
0001537561
Arch Therapeutics, Inc.
ARTH
0001260933
DHILLON AVTAR S
C/O ARCH THERAPEUTICS, INC.
235 WALNUT STREET, SUITE 6
FRAMINGHAM
MA
01702
1
0
0
0
Stock Option (right to buy)
0.425
2018-07-19
4
A
0
220000
0
A
2028-07-18
Common Stock
220000
220000
D
The Amount or Number of shares of Common Stock listed in Column 7 of the reporting person's original Form 4 was inadvertently listed as "200,000".
The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the "Company") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time.
Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date.
/s/ Avtar S. Dhillon
2018-07-20